Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

British scientists have hailed the US approval of a new drug for schizophrenia, saying it “has the potential to change the ...

Average premiums and benefits for Medicare's prescription drug program and private Medicare plans are projected to remain ...

While one brand has withdrawn the affected products, a second, Darwin's Natural Pet Products, has not, according to the FDA.

Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

Answers Pet Food and Darwin’s Natural Pet Products, were found to have produced pet food that was contaminated with the ...

We wouldn’t allow a new drug to be sold without thorough testing for safety and efficacy, so why should AI be any different?

A growing body of research shows that exposure can increase the risk of prostate, kidney and testicular cancers. The ...

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...